Correlation Between Arcellx and Vaxcyte
Can any of the company-specific risk be diversified away by investing in both Arcellx and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcellx and Vaxcyte, you can compare the effects of market volatilities on Arcellx and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and Vaxcyte.
Diversification Opportunities for Arcellx and Vaxcyte
Average diversification
The 3 months correlation between Arcellx and Vaxcyte is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Arcellx i.e., Arcellx and Vaxcyte go up and down completely randomly.
Pair Corralation between Arcellx and Vaxcyte
Given the investment horizon of 90 days Arcellx is expected to generate 1.36 times more return on investment than Vaxcyte. However, Arcellx is 1.36 times more volatile than Vaxcyte. It trades about 0.08 of its potential returns per unit of risk. Vaxcyte is currently generating about -0.41 per unit of risk. If you would invest 8,499 in Arcellx on August 27, 2024 and sell it today you would earn a total of 442.00 from holding Arcellx or generate 5.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arcellx vs. Vaxcyte
Performance |
| Timeline |
| Arcellx |
| Vaxcyte |
Arcellx and Vaxcyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcellx and Vaxcyte
The main advantage of trading using opposite Arcellx and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.| Arcellx vs. Nuvalent | Arcellx vs. Ventyx Biosciences | Arcellx vs. Amylyx Pharmaceuticals | Arcellx vs. Day One Biopharmaceuticals |
| Vaxcyte vs. Eliem Therapeutics | Vaxcyte vs. HCW Biologics | Vaxcyte vs. Scpharmaceuticals | Vaxcyte vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |